Author Information
Richard Osborne Day is a distinguished researcher affiliated with the Department of Clinical Pharmacology and Toxicology at St. Vincent's Hospital in Sydney, NSW, Australia. His expertise lies in the realm of pharmacology and toxicology, and he has made significant contributions to medical research, particularly in the areas of opioid therapy, heart and lung transplant pharmacotherapy, and diabetes management.Research Contributions
Richard O. Day has contributed extensively to the field of clinical pharmacology, with a focus on the efficacy and safety of opioid therapy, immunomodulatory effects of pharmaceuticals, and drug monitoring in clinical settings. His recent work includes a systematic review and meta-analysis on opioid therapy for osteoarthritis, a randomized trial on opioid analgesia for spinal pain, and studies on the immunomodulatory effects of opioids. Additionally, he has researched the relationship between tacrolimus exposure and toxicity in transplant recipients and the prescribing practices of SGLT2 inhibitors in primary care. His efforts have enhanced understanding of drug efficacy, safety, and prescribing practices, impacting patient care and treatment outcomes.Aliases
Richard O. Day is known by several aliases, including R O Day, R Day, Richard Day, Ric O Day, R. Day, Ric Day, Richard O. Day, Richard O Day, Richard Osborne Day, and Ric O. Day. These variations may appear across different publications and research databases.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
14,856 |
| h-index |
56 |
| Paper Count |
463 |
